Spanish heart study maps Real-World stent drug use
NCT ID NCT05193019
Summary
This study is observing how doctors in Spain currently use injectable blood-thinning medications during heart stent procedures. It will track about 1,000 patients who receive these injections to see what short-term outcomes occur, like complications or side effects. The goal is to understand real-world practice patterns and the safety of these common treatments, not to test a new drug or change patient care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H.de Leon
León, 24080, Spain
-
Hospital Central de La Defensa Gómez Ulla
Madrid, 28047, Spain
-
Hospital Clinico Universitario Santiago de Compostela
Santiago de Compostela, 15706, Spain
-
Hospital Clinico Universitario de Salamanca
Salamanca, 37007, Spain
-
Hospital Universitari Joan Xxiii
Tarragona, 43005, Spain
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Hospital Universitario Lozano Blesa
Zaragoza, 50009, Spain
-
Hospital Universitario Marques de Valdecilla
Santander, 39008, Spain
-
Hospital Universitario de Cabueñes
Gijón, 33394, Spain
-
Hospital Universitario de Cruces
Barakaldo, 48903, Spain
-
Hospital Universitario de Navarra
Pamplona, 31008, Spain
-
Hospital de Galdakao
Galdakao, 48960, Spain
Conditions
Explore the condition pages connected to this study.